MariMed Inc. reported its financial results for the third quarter of 2025, revealing a slight increase in revenue but a continued net loss. The company generated $40.8 million in revenue for the three months ending September 30, 2025, compared to $40.6 million for the same period in 2024, marking a 0.4% increase. However, the net loss attributable to common stockholders widened to $2.9 million, compared to a loss of $1.0 million in the prior year. For the nine months ended September 30, 2025, total revenue was $118.2 million, down from $118.8 million in 2024, while the net loss increased to $9.9 million from $4.2 million.

The company’s financial performance was impacted by a mix of factors, including a decline in retail sales, which fell by 3.5% year-over-year, primarily due to lower sales at its Metropolis, Illinois dispensary. Conversely, wholesale sales increased by 10.6%, contributing positively to the overall revenue. The decrease in retail sales was partially offset by the inclusion of revenue from the First State Compassion Center (FSC), which MariMed acquired effective March 1, 2025. The acquisition of FSC is expected to enhance the company’s market presence in Delaware.

Operationally, MariMed has been focusing on strategic growth initiatives, including expanding its product offerings and geographic footprint. The company has increased its employee headcount to support its expanded operations, which contributed to a rise in personnel costs. As of September 30, 2025, the company reported total current assets of $60.1 million, up from $53.5 million at the end of 2024, driven by an increase in inventory levels, which rose to $40.0 million from $33.5 million.

In terms of future outlook, MariMed is actively pursuing additional acquisitions and expanding its distribution network. The company has also entered into a Management Services Agreement with Standard Farms, which will allow it to manage a cultivation and processing facility in Pennsylvania. This agreement is part of MariMed's broader strategy to enhance its operational capabilities and market reach. The company anticipates that these strategic initiatives will contribute to improved financial performance in the upcoming quarters, despite the challenges posed by the current economic environment and regulatory landscape.

About MARIMED INC.

Marimed Inc. is a multi-state U.S. cannabis operator developing, owning, and managing licensed cultivation, production, and retail facilities. It offers proprietary brands of premium cannabis flower, concentrates, edibles, and innovative products. Serving adult-use and medical markets, it distributes wholesale and operates dispensaries, emphasizing quality, brand development, and consumer experience. Its business model combines vertical integration, brand licensing, and strategic acquisitions to drive growth and market share.

This description was generated via AI from an annual report. Updated 8 months ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.